Skip to main content
  • Home
  • Vascular Interventions Online 2021 - Venous - Part 1

Vascular Interventions Online 2021 - Venous - Part 1

Topic:
  • Intervention
  • Vascular

Available Credit:

  • 2.00 European Board for Accreditation in Cardiology (EBAC)

Course Published On:

Course Expiry Date:

Overview

In this session, Venous – Part 1, part of Vascular Interventions Online 2021, a leading faculty discuss topics such as acute DVT and great saphenous vein recurrent reflux.

 

To further illustrate this, the event will feature a number of practical demonstrations in the form of live cases broadcast from cardiovascular centers, such as Stony Brook University.

 

This session also features live cases on chronic venous obstruction/acute DVT from Guy’s and St Thomas’ NHS Foundation Trust, London; as well as a live case on chronic deep venous disease from Erasmus MC, Rotterdam, NL.

 

Vascular Interventions Online (VIO) aims to educate vascular professionals, interventionalists and surgeons who are involved and/or interested in vascular interventional treatment with a focus on Aortic, Venous and PAD / Lower Limb.

Disclosure

In compliance with EBAC / EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.

 

The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

 

This programme is supported by unrestricted educational grants from the following companies. The scientific programme has not been influenced in any way by the sponsors.

 

  • Bentley
  • Shockwave Medical

Terms & Conditions

Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

 

The session of ‘Vascular Interventions Online 2021 - Vascular interventions online – Venous – Part 1’  is accredited by the European Board for Accreditation in Cardiology (EBAC) for 2 hours of external CME credits.

 

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

 

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

Instructions to Participants

There is no fee for taking part in this online learning activity.

 

Activities are designed to be completed within 120 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

 

To complete the course and claim certification participants must:

 

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.

 

  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

Target Audience

This programme is intended to educate:

  • Vascular professionals, interventionalists and surgeons who are involved and/or interested in Aortic, Venous, and PAD / Lower Limb

Learning Objectives

The overall programme, Vascular Interventions Online 2021, endeavours to best address the following learning objectives:

  • To develop an understanding of available treatment strategies for challenging and difficult access procedures
  • To update knowledge on the latest technological developments and options
  • To gain insight into tips and tricks employed at leading international centres
Register now Log in

Chair

Stephen Black

Radcliffe Vascular

Dr Stephen Black, MD, is the clinical lead for vascular surgery at Guy’s and St Thomas’ Hospital. Dr Black is also co-R&D lead for the Cardiovascular Directorate (Cardiology, Cardio-Thoracic and Vascular Surgery).      

        

View full profile

Panelist

Kush R Desai

Northwestern University, Chicago, IL, US

View full profile

Rick de Graaf

Clinical Centre of Friedrichshafen, Friedrichshafen, Germany

Dr Rick de Graaf studied medicine at the University of Maastricht, the Netherlands. He obtained his PhD at the Department of Surgery and Medical Microbiology of the Maastricht University Medical Centre.

View full profile

Nicos Labropoulos

Stony Brook University Medical Center, Stony Brook, NY, US

Dr Nicos Labropoulos is a professor of surgery & Radiology and Director - Non Invasive vascular laboratory at Stony Brook University Medical Center, Stony Brook, NY, US.

 

View full profile

Operator

Hayley Moore

Guy’s and St Thomas’ NHS Foundation Trust, London, UK

View full profile

Prakash Saha

Prakash Saha is a clinical senior lecturer at Kings College and honorary consultant endovascular surgeon at Guy's and St Thomas' Hospital, London, UK where he is the clinical lead for venous and lymphoedema surgery.

 

View full profile

Marie-Josee Van Rijn

Erasmus University Medical Center, Rotterdam, the Netherlands

View full profile

Adriaan Moelker

Erasmus University Medical Center, Rotterdam, the Netherlands

Since 2011, Dr Adriaan Moelker has been head of the Section of Interventional Radiology, the largest interventional radiology practice in the Netherlands with six interventional radiologists, two neuro interventionalists, fellows and residents.

View full profile

2.00 European Board for Accreditation in Cardiology (EBAC)

Related Courses

Severe Aortic Stenosis: Stratifying Patients for Lifetime Management
  • 1 EBAC

Learning objectives

  • Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
  • Summarise clinical evidence for TAVI in low surgical risk patients
  • Recall different guideline recommendations for SAVR and TAVI approaches
  • Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient
See more
Renal Denervation In The Real World: Practical Guidance For New Users
  • 1 EBAC

Learning objectives

  • Assess the current global burden of resistant hypertension
  • Carry out appropriate assessments to identify resistant hypertension
  • Identify patients most likely to benefit from RDN
  • Recall the practical considerations for adopting RDN into routine practice
  • Recall the latest data on RDN from recent clinical trials
See more
Getting it Right First Time in Severe Aortic Stenosis - Key insights for Long Term Success
  • 1 EBAC

Learning objectives

  • Recall current and predicted trends in TAVI with respect to preserving coronary access
  • Consider determining factors for choosing valves in low risk populations
  • Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
See more
Optimising Outcomes For The Tavi Patient: Key Considerations For First Valve Choice And Implantation Techniques

Learning objectives

  • Recall the latest data showing why durability and hemodynamics matter for initial valve selection
  • Discuss the latest techniques to help achieve optimal outcomes for patients with longer life expectancy
  • Review TAVI cases that highlight procedure optimisation with the Evolut pro+ platform
See more
Transcatheter Interventions Online - Session 3.4: Debates
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 3.3: Keynote & Controversies: Live Cases And Discussion
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 3.1 & 3.2: Keynote & Controversies
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.4 Practical Pearls Toward a More Advanced CTO Programme: Live Cases and Discussion
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.3: Practical Pearls Toward a More Advanced CTO Programme
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more
Transcatheter Interventions Online - Session 2.2: Strategies For Calcified Coronary Lesions Anno 2022: Live Cases And Discussion
  • 1 EBAC

Learning objectives

  • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
  • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
  • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
  • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
  • Discuss the need for gender-specific trials and renal denervation
See more